Prophylaxis of topical levofloxacin against endophthalmitis after cataract surgery in Taiwan, 2001–2019: an interrupted time series analysis

Hashemian H, Mirshahi R, Khodaparast M, et al. Post-cataract surgery endophthalmitis: brief literature review. J Curr Ophthalmol. 2016;28:101–5.

Article  PubMed  PubMed Central  Google Scholar 

Jabbarvand M, Hashemian H, Khodaparast M, et al. Retraction notice to: endophthalmitis occurring after cataract surgery: outcomes of more than 480 000 cataract surgeries, epidemiologic features, and risk factors. Ophthalmology. 2016;123:295–301.

Article  PubMed  Google Scholar 

Packer M, Chang DF, Dewey SH, et al. Prevention, diagnosis, and management of acute postoperative bacterial endophthalmitis. J Cataract Refract Surg. 2011;37:1699–714.

Article  PubMed  Google Scholar 

Shi SL, Yu XN, Cui YL, et al. Incidence of endophthalmitis after phacoemulsification cataract surgery: a meta-analysis. Int J Ophthalmol. 2022;15:327–35.

Article  PubMed  PubMed Central  Google Scholar 

Zafar S, Dun C, Srikumaran D, et al. Endophthalmitis rates among medicare beneficiaries undergoing cataract surgery between 2011 and 2019. Ophthalmology. 2022;129:250–7.

Article  PubMed  Google Scholar 

Hou CH, Lee JS, Lin KK, et al. Risk and dose–response relationship of diabetes mellitus for endophthalmitis after cataract surgery in a nationwide cohort study in Taiwan. Clin Exp Ophthalmol. 2023;51:692–703.

Article  PubMed  Google Scholar 

Ciulla TA, Starr MB, Masket S. Bacterial endophthalmitis prophylaxis for cataract surgery: an evidence-based update. Ophthalmology. 2002;109:13–24.

Article  PubMed  Google Scholar 

Behndig A, Cochener B, Güell JL, et al. Endophthalmitis prophylaxis in cataract surgery: overview of current practice patterns in 9 European countries. J Cataract Refract Surg. 2013;39:1421–31.

Article  PubMed  Google Scholar 

Escrs Endophthalmitis Study Group. Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors. J Cataract Refract Surg. 2007;33:978–88.

Article  Google Scholar 

Han DC, Chee SP. Survey of practice preference pattern in antibiotic prophylaxis against endophthalmitis after cataract surgery in Singapore. Int Ophthalmol. 2012;32:127–34.

Article  PubMed  Google Scholar 

Chang DF, Rhee DJ. Antibiotic prophylaxis of postoperative endophthalmitis after cataract surgery: results of the 2021 ASCRS member survey. J Cataract Refract Surg. 2022;48:3–7.

Article  PubMed  Google Scholar 

Çakır B, Celik E, Aksoy NÖ, et al. Toxic anterior segment syndrome after uncomplicated cataract surgery possibly associated with intracamaral use of cefuroxime. Clin Ophthalmol. 2015;9:493–7.

Article  PubMed  PubMed Central  Google Scholar 

Das T, Joseph J, Simunovic M, et al. Consensus and controversies in the science of endophthalmitis management: basic research and clinical perspectives. Prog Retin Eye Res. 2023;97:101218.

Article  PubMed  Google Scholar 

Sherman RE, Anderson SA, Dal Pan GJ, et al. Real-world evidence—what is it and what can it tell us. N Engl J Med. 2016;375:2293–7.

Article  PubMed  Google Scholar 

Najafzadeh M, Schneeweiss S. From trial to target populations—calibrating real-world data. N Engl J Med. 2017;376:1203–5.

Article  PubMed  Google Scholar 

Bernal JL, Cummins S, Gasparrini A. Interrupted time series regression for the evaluation of public health interventions: A tutorial. Int J Epidemiol. 2017;46:348–55.

PubMed  Google Scholar 

Gower EW, Lindsley K, Tulenko SE, et al. Perioperative antibiotics for prevention of acute endophthalmitis after cataract surgery. Cochrane Database Syst Rev. 2017;2:CD006364.

PubMed  Google Scholar 

Hsieh CY, Su CC, Shao SC, et al. Taiwan’s national health insurance research database: past and future. Clin Epidemiol. 2019;11:349–58.

Article  PubMed  PubMed Central  Google Scholar 

Wu CS, Lai MS, Gau SSF, et al. Concordance between patient self-reports and claims data on clinical diagnoses, medication use, and health system utilization in Taiwan. PLoS ONE. 2014;9:e112257.

Article  PubMed  PubMed Central  Google Scholar 

National Health Insurance Administration, Ministry of Health and Welfare, Taiwan. Payment code inquiry for diagnosis, procedure, and medication. https://info.nhi.gov.tw/INAE5000/INAE5001S01. Accessed 28 Oct 2024.

Ng J, Morlet N, Clark A. Anterior vitrectomy at the time of cataract surgery: a whole-population study of the incidence and consequences. Invest Ophthalmol Vis Sci. 2013;54:893–893.

Google Scholar 

Charlson ME, Carrozzino D, Guidi J, et al. Charlson comorbidity index: a critical review of clinimetric properties. Psychother Psychosom. 2022;91:8–35.

Article  PubMed  Google Scholar 

D’hoore W, Sicotte C, Tilquin C. Risk adjustment in outcome assessment: the Charlson comorbidity index. Methods Inf Med. 1993;32:382–7.

Article  PubMed  Google Scholar 

Xu S, Ross C, Raebel MA, et al. Use of stabilized inverse propensity scores as weights to directly estimate relative risk and its confidence intervals. Value Health. 2010;13:273–7.

Article  PubMed  Google Scholar 

Mccaffrey DF, Griffin BA, Almirall D, et al. A tutorial on propensity score estimation for multiple treatments using generalized boosted models. Stat Med. 2013;32:3388–414.

Article  PubMed  PubMed Central  Google Scholar 

Austin PC. Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research. Commun Stat Simul Comput. 2009;38:1228–34.

Article  Google Scholar 

Division of Cancer Control and Population Sciences, National Cancer Institute. How joinpoint selects the final model. https://surveillance.cancer.gov/help/joinpoint/setting-parameters/method-and-parameters-tab/model-selection-method. Accessed 04 Dec 2024.

Wagner AK, Soumerai SB, Zhang F, et al. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther. 2002;27:299–309.

Article  CAS  PubMed  Google Scholar 

Hu Y, Van Lenthe FJ, Hoffmann R, et al. Assessing the impact of natural policy experiments on socioeconomic inequalities in health: How to apply commonly used quantitative analytical methods? BMC Med Res Methodol. 2017;17:68.

Article  PubMed  PubMed Central  Google Scholar 

Schober P, Boer C, Schwarte LA. Correlation coefficients: appropriate use and interpretation. Anesth Analg. 2018;126:1763–8.

Article  PubMed  Google Scholar 

Chang DF, Braga-Mele R, Henderson BA, et al. Antibiotic prophylaxis of postoperative endophthalmitis after cataract surgery: results of the 2014 ASCRS member survey. J Cataract Refract Surg. 2015;41:1300–5.

Article  PubMed  Google Scholar 

Haripriya A. Antibiotic prophylaxis in cataract surger: an evidence-based approach. Indian J Ophthalmol. 2017;65:1390–5.

Article  PubMed  PubMed Central  Google Scholar 

Chang DF, Braga-Mele R, Mamalis N, et al. Prophylaxis of postoperative endophthalmitis after cataract surgery: results of the 2007 ASCRS member survey. J Cataract Refract Surg. 2007;33:1801–5.

Article  PubMed  Google Scholar 

Keating GM. Levofloxacin 0.5% ophthalmic solution. Drugs. 2009;69:1267–86.

Article  CAS  PubMed  Google Scholar 

Drlica K. Mechanism of fluoroquinolone action. Curr Opin Microbiol. 1999;2:504–8.

Article  CAS  PubMed  Google Scholar 

Kim SY, Lim JA, Choi JS, et al. Comparison of antibiotic effect & corneal epithelial toxicity between levofloxacin 0.5% (Cravit®) & moxifloxacin 0.5% (Vigamox®) in vitro. Invest Ophthalmol Vis Sci. 2006;47:3565–3565.

Google Scholar 

Han KE, Chung WS, Kim TI, et al. Epithelial wound healing after cataract surgery comparing two different topical fluoroquinolones. Yonsei Med J. 2014;55:197–202.

Article  CAS  PubMed  Google Scholar 

Edwar L, Bisara BB, Setiabudi R, et al. Safety of intracameral injection of levofloxacin 0.5% eye drops single dose 0.6 ml preservative free on rabbit eye. F1000Res. 2023;12:772.

留言 (0)

沒有登入
gif